Arcturus Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $17,151 | $24,510 | $29,382 | $21,000 |
Gross Profit | 13,809 | 24,510 | 29,382 | 21,000 |
EBITDA | -12,685 | -10,837 | -16,025 | -29,190 |
EBIT | -13,448 | -11,616 | -16,826 | -30,009 |
Net Income | -13,448 | -9,180 | -14,076 | -30,005 |
Net Change In Cash | 17,151 | 24,510 | 29,382 | 21,000 |
Free Cash Flow | -17,332 | -5,755 | -35,275 | -284 |
Cash | 180,360 | 196,467 | 216,948 | 237,028 |
Basic Shares | 27,188 | 27,129 | 27,107 | 27,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $138,389 | $157,748 | $205,755 | $12,359 |
Gross Profit | 138,389 | 157,748 | 205,755 | 12,359 |
EBITDA | -77,401 | -24,165 | 13,704 | -201,659 |
EBIT | -80,945 | -27,122 | 12,177 | -202,852 |
Net Income | -80,941 | -29,725 | 9,349 | -203,674 |
Net Change In Cash | 138,389 | 157,748 | 205,755 | 12,359 |
Cost of Revenue | -90,433 | |||
Free Cash Flow | -60,395 | -21,000 | 24,267 | -138,449 |
Cash | 237,028 | 292,005 | 391,883 | 370,492 |
Basic Shares | 27,000 | 26,628 | 27,093 | 26,317 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.49 |
2025-06-30 | -$0.34 |
2025-03-31 | -$0.52 |
2024-12-31 | -$1.11 |
